News

Newly approved therapy could offer another option for protecting infants from RSV, a common infection that can be deadly
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...
Fierce Pharma1d
Merck scores FDA nod for Enflonsia, setting up RSV market battle vs. Sanofi and AstraZeneca's Beyfortus
Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...
Us Weekly9h
Mormon Wives’ Mikayla Brings Up Whitney’s Controversial RSV Dance Video Amid Feud: ‘It Slayed’
The Secret Lives of Mormon Wives' costars Whitney Leavitt and Mikayla Matthews have been feuding since season 1 of the hit ...
hMPV is likely one of the viruses making us sick this season. Here's what to know about human metapneumovirus
As winter settles over Australia, it's not just the drop in temperature we notice—there's also a sharp rise in respiratory ...
STAT14h
Pharmalittle: We’re reading about a Merck shot for RSV, a lawsuit over an Arkansas PBM law, and more
Merck won FDA approval for a shot that protects against RSV, the most common cause of hospitalization among infants ...
CIDRAP1d
RSV, flu linked to 6% and 3% of kids' antibiotic prescriptions
Estimates varied from 2008 through 2018, with RSV-associated antibiotic prescribing exceeding 10% in peak RSV years and ...
Explore more
Health Talk: WHO flags RSV deaths in children, calls for new immunisation tools
RSV is responsible for around 1 lakh deaths, over 3.6 million hospitalisations in children under age of 5 every year, ...